Vaxart
Vaccine technology for the treatment of infectious diseases. Learn more
Launch date
Employees
Market cap
€186m
Enterprise valuation
€147m (Public information from Sep 2024)
Share price
$0.8344 VXRT
San Francisco California (HQ)
Authorizing premium user...